Reduced Melanoma After Regular Sunscreen Use: Randomized Trial Follow-Up
GLP-1 Receptor Agonists or SGLT2 Inhibitors and Nonarteritic Anterior Ischemic Optic Neuropathy
* Previously discussed on Fornight XXII: Glucagon-like peptide-1 receptor agonists and risk of substance use disorders among US veterans with type 2 diabetes: cohort study
This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.sensible-med.com/subscribe
Fler avsnitt av Sensible Medicine
Visa alla avsnitt av Sensible MedicineSensible Medicine med Sensible Medicine Authors and Editors finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
